Furious FDA Advisors Resign to Protest Approval of Alzheimer's Drug That They Say Doesn't Work
The US Food and Drug Administration (FDA) recently approved aducanumab, the first new Alzheimer's disease medication to given the honor in 18 years — and three ... Read more